# Amsel Medical awarded $7.45M SBIR contract from U.S. Air Force

Amsel Medical Corporation has been awarded a $7.45 million sole-source SBIR Phase III contract by the U.S. Air Force to commercialize its SCureTO hemorrhage control device for combat casualty care.

- Type: Contract
- Announced: 2024-10-02
- Where: United States
- Value: $7.45M
- Status: completed
- Products: SCureTO temporary vascular occlusion clamp
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Amsel Medical Corporation](https://endata.com/companies/80205.md)
- [United States Air Force](https://endata.com/companies/18070.md) (customer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/amsel-medical-signs-7-45m-phase-iii-sbir-contract-302265024.html), 2024-10-02: "Amsel Medical Corporation today announces that it has been awarded an $7.45 million sole source, non-dilutive, small business innovative research (SBIR) Phase III contract by the United States Air Force."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.